BigHat Biosciences, Inc. — Form D
BigHat Biosciences, Inc. of SAN MATEO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2022-10-03. The offering totals $80.0M, of which $80.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2022-10-03
- Form: D
- Accession: 0001797256-22-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $80.0M
- Amount sold: $80.0M
- Remaining: $102
- Investors: 27
- Date of first sale: 2022-06-30
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-460544
Issuer
- Name: BigHat Biosciences, Inc.
- CIK: 0001797256
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 1900 ALAMEDA DE LAS PULGAS, SAN MATEO, CA, 94403
- Phone: 857-928-5232
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Mark DePristo | Director | San Mateo, CA |
| Mark DePristo | Executive Officer | San Mateo, CA |
| Francisco Gimenez | Director | Minneapolis, MN |
| Vineeta Agarwala | Director | Menlo Park, CA |
| Robert Chess | Director | Lafayette, CA |
| Peyton Greenside | Director | San Mateo, CA |
| Peyton Greenside | Executive Officer | San Mateo, CA |
| Steve Kafka | Director | San Mateo, CA |
| Theresa Tribble | Promoter | Cambridge, MA |
Other filings by this issuer (3)
More